Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 15, 2019 - Issue
Submit an article Journal homepage
88
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?

Balázs Németh1 Dermatology Unit, Zsigmondy Vilmos SPA Hospital, Harkány, Hungary;2 Department of Public Health Medicine, Medical School, University of Pécs, Pécs, HungaryCorrespondence[email protected]
,
Iván Péter1 Dermatology Unit, Zsigmondy Vilmos SPA Hospital, Harkány, Hungary
,
Imre Boncz1 Dermatology Unit, Zsigmondy Vilmos SPA Hospital, Harkány, Hungary
,
Anna Jagicza1 Dermatology Unit, Zsigmondy Vilmos SPA Hospital, Harkány, Hungary
,
István Kiss2 Department of Public Health Medicine, Medical School, University of Pécs, Pécs, Hungary
,
Ágnes Csergő2 Department of Public Health Medicine, Medical School, University of Pécs, Pécs, Hungary
,
Tamás Kőszegi3 Department of Laboratory Medicine, Medical School, University of Pécs, Pécs, Hungary;4 János Szentágothai Research Centre, University of Pécs, Pécs, Hungary
,
Péter Kustán3 Department of Laboratory Medicine, Medical School, University of Pécs, Pécs, Hungary;4 János Szentágothai Research Centre, University of Pécs, Pécs, Hungary
,
Iván G Horváth5 Heart Institute, Medical School, University of Pécs, Pécs, Hungary
&
Zénó Ajtay1 Dermatology Unit, Zsigmondy Vilmos SPA Hospital, Harkány, Hungary;5 Heart Institute, Medical School, University of Pécs, Pécs, Hungary
 show all
Pages 831-837 | Published online: 05 Jul 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Runa M. Andreassen, Jens B. Kronborg, Henrik Schirmer, Ellisiv B. Mathiesen, Toralf Melsom, Bjørn O. Eriksen, Trond G. Jenssen & Marit D. Solbu. (2022) Urinary orosomucoid is associated with diastolic dysfunction and carotid arteriopathy in the general population. Cross-sectional data from the Tromsø study. Scandinavian Cardiovascular Journal 56:1, pages 148-156.
Read now

Articles from other publishers (4)

Hesham N. Khalid, Eman M. Abd El Gayed, Asmaa M. A. Elrsool & Heba A. S. Bazid. (2021) Evaluation of serum and urinary orsomucoid protein A in psoriatic patients and their relation to severity of disease. Journal of Cosmetic Dermatology 21:3, pages 1185-1192.
Crossref
Meijing Shi, Xiuru Ma, Qian Yang, Wenjing Wang, Xinning Li, Xuelian Song, Yingxiao Li, Yuetao Xie & Yi Dang. (2021) miR-362-3p Targets Orosomucoid 1 to Promote Cell Proliferation, Restrain Cell Apoptosis and Thereby Mitigate Hypoxia/Reoxygenation-Induced Cardiomyocytes Injury. Cardiovascular Toxicology 21:5, pages 387-398.
Crossref
José Manuel Fernández Armenteros & Joan Àngel Baldó. (2021) Psoriasis, inflamación y riesgo cardiovascular. Piel 36:4, pages 241-245.
Crossref
Sharathshiva Valaiyaduppu Subas, Vinayak Mishra, Vishal Busa, Ishan Antony, Suganya Marudhai, Mauli Patel & Ivan Cancarevic. (2020) Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review. Cureus.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.